• Medgaz will carry out during the year 2023 the necessary studies aimed to examine the compatibility of its infrastructures for the transportation of hydrogen and blending with natural gas.

Almería, 18/11/2022

In its firm desire to support energy changes and mutations towards a cleaner environment, Medgaz has agreed to carry out relevant studies to adapt existing facilities to the combined transport of natural gas and hydrogen. A market which, according to several forecasts, offers prospects for interesting and promising development, particularly in Europe.

To this end, Medgaz will carry out during the year 2023 the necessary studies in order to examine the compatibility of its infrastructures with the transport of hydrogen according to several proportions of blending with natural gas. At the same time, a working group will be set up to develop business opportunities in this area.

Medgaz has the firm intention of aligning and adapting to the standards being developed in Algeria, Spain and Europe, relating to the transport of hydrogen by gas pipelines. Thus, offering a reliable energy supply infrastructure for Europe with a low carbon footprint.

It should be recalled that Medgaz has just completed the extension of its facilities with the start-up of a fourth compressor at the Béni Saf station (Algeria) which will increase the transport capacity to 10 bcm per year.

The shareholders of Medgaz are Sonatrach with a 51% stake and Medina Partnership (50% joint venture between Naturgy and BlackRock) with the remaining 49%.

MEDGAZ SA
Press contact
contacto_prensa@medgaz.com
www.medgaz.com